Acceleron Pharma, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $304,887 | 93 | 50.7% |
| Unspecified | $266,809 | 73 | 44.4% |
| Food and Beverage | $26,893 | 1,549 | 4.5% |
| Space rental or facility fees (teaching hospital only) | $1,000 | 1 | 0.2% |
| Travel and Lodging | $907.38 | 6 | 0.2% |
| Education | $884.54 | 19 | 0.1% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (STELLAR) | $129,868 | 0 | 28 |
| A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH) | $82,428 | 1 | 27 |
| A Long-term Follow-up Study of Sotatercept for PAH Treatment | $49,560 | 0 | 12 |
| Study of Sotatercept in Newly Diagnosed Intermediate- and High-risk PAH Patients | $2,285 | 1 | 3 |
| A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality | $1,968 | 2 | 2 |
| A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension | $700.00 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2021 |
|---|---|---|---|---|
| Dr. Ellis Neufeld, Md, MD | Pediatric Hematology-Oncology | Memphis, TN | $17,235 | $0 |
| Andrew Brunner, M.d, M.D | Hematology & Oncology | Boston, MA | $12,575 | $0 |
| Rami Komrokji, M.d, M.D | Hematology | Tampa, FL | $10,140 | $0 |
| Dr. Kai Zu, M.d, M.D | Hematology & Oncology | La Mesa, CA | $9,610 | $0 |
| Dr. Geetha Puthenveetil, M.d, M.D | Pediatric Hematology-Oncology | Los Angeles, CA | $9,480 | $0 |
| Dr. Daniel Landau, Md, MD | Hematology & Oncology | Orlando, FL | $9,480 | $0 |
| Noah Merin, M.d, M.D | Student in an Organized Health Care Education/Training Program | West Hollywood, CA | $8,903 | $0 |
| Harshad Amin, M.d, M.D | Hematology & Oncology | Plantation, FL | $7,430 | $0 |
| Anusha Madadi, Md, MD | Medical Oncology | Fayetteville, NC | $7,250 | $0 |
| Dr. Guillermo Lazo-Diaz, Md, MD | Medical Oncology | Mcallen, TX | $7,250 | $0 |
| Dr. Mark Ewalt, M.d, M.D | Cytopathology | New York, NY | $7,040 | $0 |
| Dr. James Mangan, Md, MD | Hematology & Oncology | San Diego, CA | $7,010 | $0 |
| Mr. Vinod Pullarkat, M.d, M.D | Hematology | Duarte, CA | $6,819 | $0 |
| Raghuveer Ranganathan, M.d, M.D | Hematology & Oncology | Los Angeles, CA | $6,791 | $0 |
| Vallerie Mclaughlin, Md, MD | Internal Medicine | Ann Arbor, MI | $6,777 | $0 |
| Tony Cheung, Md, MD | Hematology & Oncology | Valley Stream, NY | $6,410 | $0 |
| Cyrus Khan, M.d, M.D | Hematology & Oncology | Pittsburgh, PA | $6,195 | $0 |
| Dr. Sujit Sheth | Pediatric Hematology-Oncology | New York, NY | $5,940 | $0 |
| Dr. Govind Bhagat | Hematology | Saint Louis, MO | $5,490 | $0 |
| Dr. Michael Linden, Md, Phd, MD, PHD | Anatomic Pathology & Clinical Pathology | Minneapolis, MN | $5,490 | $0 |
| Mingyi Chen, Md, MD | Hematology | Dallas, TX | $5,490 | $0 |
| Dr. Eric Duncavage, Md, MD | Anatomic Pathology & Clinical Pathology | Saint Louis, MO | $5,490 | $0 |
| Dr. Ryan Tedford, M.d, M.D | Internal Medicine | Charleston, SC | $5,340 | $0 |
| Raymond Benza, Md, MD | Cardiovascular Disease | Norfolk, VA | $5,340 | $0 |
| Livia Hegerova, Md, MD | Internal Medicine | Seattle, WA | $4,760 | $0 |
About Acceleron Pharma, Inc.
Acceleron Pharma, Inc. has made $601,381 in payments to 1,075 healthcare providers, recorded across 1,741 transactions in the CMS Open Payments database. In 2021, the company paid $426,862. The top product by payment volume is Reblozyl ($298,873).
Payments were distributed across 59 medical specialties. The top specialty by payment amount is Hematology & Oncology ($133,036 to 391 doctors).
Payment categories include: Food & Beverage ($26,893), Consulting ($304,887), Research ($266,809), Travel & Lodging ($907.38).
Acceleron Pharma, Inc. is associated with 1 products in the CMS Open Payments database.